Skip to main content

previous disabled Page of 3
and
  1. Article

    Open Access

    Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profiling

    The Illumina family of Infinium Methylation BeadChip microarrays has been widely used over the last 15 years for genome-wide DNA methylation profiling, including large-scale and population-based studies, due t...

    Timothy J. Peters, Braydon Meyer, Lauren Ryan, Joanna Achinger-Kawecka in BMC Genomics (2024)

  2. Article

    Open Access

    The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer

    Three-dimensional (3D) epigenome remodeling is an important mechanism of gene deregulation in cancer. However, its potential as a target to counteract therapy resistance remains largely unaddressed. Here, we s...

    Joanna Achinger-Kawecka, Clare Stirzaker in Nature Structural & Molecular Biology (2024)

  3. Article

    Open Access

    A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer

    The lysyl oxidase family represents a promising target in stromal targeting of solid tumors due to the importance of this family in crosslinking and stabilizing fibrillar collagens and its known role in tumor ...

    Jessica L. Chitty, Michelle Yam, Lara Perryman, Amelia L. Parker in Nature Cancer (2023)

  4. No Access

    Protocol

    Target-Specific Profiling of RNA m5C Methylation Level Using Amplicon Sequencing

    Map** the position and quantifying the level of 5-methylcytosine (m5C) as a modification in different types of cellular RNA is an important objective in the field of epitranscriptomics. Bisulfite conversion has...

    Tennille Sibbritt, Ulrike Schumann, Andrew Shafik in Post-Transcriptional Gene Regulation (2022)

  5. Article

    Open Access

    Identification of DNA methylation biomarkers with potential to predict response to neoadjuvant chemotherapy in triple-negative breast cancer

    Neoadjuvant chemotherapy (NAC) is used to treat triple-negative breast cancer (TNBC) prior to resection. Biomarkers that accurately predict a patient’s response to NAC are needed to individualise therapy and a...

    Braydon Meyer, Samuel Clifton, Warwick Locke, Phuc-Loi Luu, Qian Du in Clinical Epigenetics (2021)

  6. Article

    Open Access

    BRG1 knockdown inhibits proliferation through multiple cellular pathways in prostate cancer

    BRG1 (encoded by SMARCA4) is a catalytic component of the SWI/SNF chromatin remodelling complex, with key roles in modulating DNA accessibility. Dysregulation of BRG1 is observed, but functionally uncharacterised...

    Katherine A. Giles, Cathryn M. Gould, Joanna Achinger-Kawecka in Clinical Epigenetics (2021)

  7. Article

    Open Access

    Comprehensive evaluation of targeted multiplex bisulphite PCR sequencing for validation of DNA methylation biomarker panels

    DNA methylation is a well-studied epigenetic mark that is frequently altered in diseases such as cancer, where specific changes are known to reflect the type and severity of the disease. Therefore, there is a ...

    Dilys Lam, Phuc-Loi Luu, Jenny Z. Song, Wenjia Qu in Clinical Epigenetics (2020)

  8. Article

    Open Access

    Multiple links between 5-methylcytosine content of mRNA and translation

    5-Methylcytosine (m5C) is a prevalent base modification in tRNA and rRNA but it also occurs more broadly in the transcriptome, including in mRNA, where it serves incompletely understood molecular functions. In pu...

    Ulrike Schumann, He-Na Zhang, Tennille Sibbritt, Anyu Pan, Attila Horvath in BMC Biology (2020)

  9. Article

    Open Access

    Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer

    Prostate cancer changes the phenotype of cells within the stromal microenvironment, including fibroblasts, which in turn promote tumour progression. Functional changes in prostate cancer-associated fibroblasts...

    Mitchell G. Lawrence, Ruth Pidsley, Birunthi Niranjan in Clinical Epigenetics (2020)

  10. Article

    Open Access

    Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer

    Endocrine therapy resistance frequently develops in estrogen receptor positive (ER+) breast cancer, but the underlying molecular mechanisms are largely unknown. Here, we show that 3-dimensional (3D) chromatin ...

    Joanna Achinger-Kawecka, Fatima Valdes-Mora, Phuc-Loi Luu in Nature Communications (2020)

  11. Article

    Open Access

    Constitutively bound CTCF sites maintain 3D chromatin architecture and long-range epigenetically regulated domains

    The architectural protein CTCF is a mediator of chromatin conformation, but how CTCF binding to DNA is orchestrated to maintain long-range gene expression is poorly understood. Here we perform RNAi knockdown t...

    Amanda Khoury, Joanna Achinger-Kawecka, Saul A. Bert in Nature Communications (2020)

  12. Article

    Open Access

    Methylome and transcriptome maps of human visceral and subcutaneous adipocytes reveal key epigenetic differences at developmental genes

    Adipocytes support key metabolic and endocrine functions of adipose tissue. Lipid is stored in two major classes of depots, namely visceral adipose (VA) and subcutaneous adipose (SA) depots. Increased visceral...

    Stephen T. Bradford, Shalima S. Nair, Aaron L. Statham in Scientific Reports (2019)

  13. Article

    Open Access

    Monozygotic twins and triplets discordant for amyotrophic lateral sclerosis display differential methylation and gene expression

    Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterised by the loss of upper and lower motor neurons. ALS exhibits high phenotypic variability including age and site of onset, an...

    Ingrid S. Tarr, Emily P. McCann, Beben Benyamin, Timothy J. Peters in Scientific Reports (2019)

  14. Article

    Open Access

    Integrated epigenomic analysis stratifies chromatin remodellers into distinct functional groups

    ATP-dependent chromatin remodelling complexes are responsible for establishing and maintaining the positions of nucleosomes. Chromatin remodellers are targeted to chromatin by transcription factors and non-cod...

    Katherine A. Giles, Cathryn M. Gould, Qian Du, Ksenia Skvortsova in Epigenetics & Chromatin (2019)

  15. Article

    Open Access

    Replication timing and epigenome remodelling are associated with the nature of chromosomal rearrangements in cancer

    DNA replication timing is known to facilitate the establishment of the epigenome, however, the intimate connection between replication timing and changes to the genome and epigenome in cancer remain largely un...

    Qian Du, Saul A. Bert, Nicola J. Armstrong, C. Elizabeth Caldon in Nature Communications (2019)

  16. Article

    Open Access

    Epigenomics of mammary gland development

    Differentiation of stem cells into highly specialised cells requires gene expression changes brought about by remodelling of the chromatin architecture. During this lineage-commitment process, the majority of ...

    Holly Holliday, Laura A. Baker, Simon R. Junankar, Susan J. Clark in Breast Cancer Research (2018)

  17. Article

    Open Access

    Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten

    Comprehensive genome-wide DNA methylation profiling is critical to gain insights into epigenetic reprogramming during development and disease processes. Among the different genome-wide DNA methylation technolo...

    Shalima S. Nair, Phuc-Loi Luu, Wenjia Qu, Madhavi Maddugoda in Epigenetics & Chromatin (2018)

  18. No Access

    Protocol

    Bisulphite Sequencing of Chromatin Immunoprecipitated DNA (BisChIP-seq)

    Epigenetic regulation plays a critical role in gene expression, cellular differentiation, and disease. There is a complex interplay between the different layers of epigenetic information, including DNA methyla...

    Clare Stirzaker, Jenny Z. Song, Aaron L. Statham in DNA Methylation Protocols (2018)

  19. Article

    Open Access

    Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer

    Acetylation of the histone variant H2A.Z (H2A.Zac) occurs at active promoters and is associated with oncogene activation in prostate cancer, but its role in enhancer function is still poorly understood. Here w...

    Fátima Valdés-Mora, Cathryn M. Gould, Yolanda Colino-Sanguino in Nature Communications (2017)

  20. Article

    Open Access

    Comprehensive evaluation of genome-wide 5-hydroxymethylcytosine profiling approaches in human DNA

    The discovery that 5-methylcytosine (5mC) can be oxidized to 5-hydroxymethylcytosine (5hmC) by the ten-eleven translocation (TET) proteins has prompted wide interest in the potential role of 5hmC in resha** ...

    Ksenia Skvortsova, Elena Zotenko, Phuc-Loi Luu, Cathryn M. Gould in Epigenetics & Chromatin (2017)

previous disabled Page of 3